                               SEQUENCE LISTING

<110> ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC.
     
<120> NOVEL MONOMERIC YELLOW-GREEN FLUORESCENT PROTEIN FROM 
      CEPHALOCHORDATE

<130> F6035-00014

<140> PCT/US2013/051911
<141> 2013-07-24

<150> 61/675,237
<151> 2012-07-24

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 236
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Met Val Ser Lys Gly Glu Glu Asp Asn Met Ala Ser Leu Pro Ala Thr 
1               5                   10                  15      


His Glu Leu His Ile Phe Gly Ser Ile Asn Gly Val Asp Phe Asp Met 
            20                  25                  30          


Val Gly Gln Gly Thr Gly Asn Pro Asn Asp Gly Tyr Glu Glu Leu Asn 
        35                  40                  45              


Leu Lys Ser Thr Lys Gly Asp Leu Gln Phe Ser Pro Trp Ile Leu Val 
    50                  55                  60                  


Pro His Ile Gly Tyr Gly Phe His Gln Tyr Leu Pro Tyr Pro Asp Gly 
65                  70                  75                  80  


Met Ser Pro Phe Gln Ala Ala Met Val Asp Gly Ser Gly Tyr Gln Val 
                85                  90                  95      


His Arg Thr Met Gln Phe Glu Asp Gly Ala Ser Leu Thr Val Asn Tyr 
            100                 105                 110         


Arg Tyr Thr Tyr Glu Gly Ser His Ile Lys Gly Glu Ala Gln Val Lys 
        115                 120                 125             


Gly Thr Gly Phe Pro Ala Asp Gly Pro Val Met Thr Asn Ser Leu Thr 
    130                 135                 140                 


Ala Ala Asp Trp Cys Arg Ser Lys Lys Thr Tyr Pro Asn Asp Lys Thr 
145                 150                 155                 160 


Ile Ile Ser Thr Phe Lys Trp Ser Tyr Thr Thr Gly Asn Gly Lys Arg 
                165                 170                 175     


Tyr Arg Ser Thr Ala Arg Thr Thr Tyr Thr Phe Ala Lys Pro Met Ala 
            180                 185                 190         


Ala Asn Tyr Leu Lys Asn Gln Pro Met Tyr Val Phe Arg Lys Thr Glu 
        195                 200                 205             


Leu Lys His Ser Lys Thr Glu Leu Asn Phe Lys Glu Trp Gln Lys Ala 
    210                 215                 220                 


Phe Thr Asp Val Met Gly Met Asp Glu Leu Tyr Lys 
225                 230                 235     


<210> 2
<211> 711
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 2
atggtgagca agggcgagga ggataacatg gcctctctcc cagcgacaca tgagttacac       60

atctttggct ccatcaacgg tgtggacttt gacatggtgg gtcagggcac cggcaatcca      120

aatgatggtt atgaggagtt aaacctgaag tccaccaagg gtgacctcca gttctccccc      180

tggattctgg tccctcatat cgggtatggc ttccatcagt acctgcccta ccctgacggg      240

atgtcgcctt tccaggccgc catggtagat ggctccggat accaagtcca tcgcacaatg      300

cagtttgaag atggtgcctc ccttactgtt aactaccgct acacctacga gggaagccac      360

atcaaaggag aggcccaggt gaaggggact ggtttccctg ctgacggtcc tgtgatgacc      420

aactcgctga ccgctgcgga ctggtgcagg tcgaagaaga cttaccccaa cgacaaaacc      480

atcatcagta cctttaagtg gagttacacc actggaaatg gcaagcgcta ccggagcact      540

gcgcggacca cctacacctt tgccaagcca atggcggcta actatctgaa gaaccagccg      600

atgtacgtgt tccgtaagac ggagctcaag cactccaaga ccgagctcaa cttcaaggag      660

tggcaaaagg cctttaccga tgtgatgggc atggacgagc tgtacaagta a               711


<210> 3
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6xHis tag

<400> 3
His His His His His His 
1               5       


<210> 4
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Ser Gly Leu Arg Ser Pro Pro Val Ala Thr 
1               5                   10  


<210> 5
<211> 219
<212> PRT
<213> Branchiostoma lanceolatum

<400> 5
Met Ser Leu Pro Ala Thr His Glu Leu His Ile Phe Gly Ser Phe Asn 
1               5                   10                  15      


Gly Val Asp Phe Asp Met Val Gly Arg Gly Thr Gly Asn Pro Asn Asp 
            20                  25                  30          


Gly Tyr Glu Glu Leu Asn Leu Lys Ser Thr Lys Gly Ala Leu Gln Phe 
        35                  40                  45              


Ser Pro Trp Ile Leu Val Pro Gln Ile Gly Tyr Gly Phe His Gln Tyr 
    50                  55                  60                  


Leu Pro Phe Pro Asp Gly Met Ser Pro Phe Gln Ala Ala Met Lys Asp 
65                  70                  75                  80  


Gly Ser Gly Tyr Gln Val His Arg Thr Met Gln Phe Glu Asp Gly Ala 
                85                  90                  95      


Ser Leu Thr Ser Asn Tyr Arg Tyr Thr Tyr Glu Gly Ser His Ile Lys 
            100                 105                 110         


Gly Glu Phe Gln Val Ile Gly Thr Gly Phe Pro Ala Asp Gly Pro Val 
        115                 120                 125             


Met Thr Asn Ser Leu Thr Ala Ala Asp Trp Cys Val Thr Lys Met Leu 
    130                 135                 140                 


Tyr Pro Asn Asp Lys Thr Ile Ile Ser Thr Phe Asp Trp Thr Tyr Thr 
145                 150                 155                 160 


Thr Gly Ser Gly Lys Arg Tyr Gln Ser Thr Val Arg Thr Asn Tyr Thr 
                165                 170                 175     


Phe Ala Lys Pro Met Ala Ala Asn Ile Leu Lys Asn Gln Pro Met Phe 
            180                 185                 190         


Val Phe Arg Lys Thr Glu Leu Lys His Ser Lys Thr Glu Leu Asn Phe 
        195                 200                 205             


Lys Glu Trp Gln Lys Ala Phe Thr Asp Val Met 
    210                 215                 


<210> 6
<211> 236
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Met Val Ser Lys Gly Glu Glu Asp Asn Met Ala Ser Leu Pro Ala Thr 
1               5                   10                  15      


His Glu Leu His Ile Phe Gly Ser Phe Asn Gly Val Asp Phe Asp Met 
            20                  25                  30          


Val Gly Arg Gly Thr Gly Asn Pro Asn Asp Gly Tyr Glu Glu Leu Asn 
        35                  40                  45              


Leu Lys Ser Thr Lys Gly Asp Leu Gln Phe Ser Pro Trp Ile Leu Val 
    50                  55                  60                  


Pro Gln Ile Gly Tyr Gly Phe His Gln Tyr Leu Pro Phe Pro Asp Gly 
65                  70                  75                  80  


Met Ser Pro Phe Gln Ala Ala Met Lys Asp Gly Ser Gly Tyr Gln Val 
                85                  90                  95      


His Arg Thr Met Gln Phe Glu Asp Gly Ala Ser Leu Thr Ser Asn Tyr 
            100                 105                 110         


Arg Tyr Thr Tyr Glu Gly Ser His Ile Lys Gly Glu Phe Gln Val Lys 
        115                 120                 125             


Gly Thr Gly Phe Pro Ala Asp Gly Pro Val Met Thr Asn Ser Leu Thr 
    130                 135                 140                 


Ala Ala Asp Trp Cys Val Thr Lys Met Leu Tyr Pro Asn Asp Lys Thr 
145                 150                 155                 160 


Ile Ile Ser Thr Phe Asp Trp Thr Tyr Thr Thr Gly Asn Gly Lys Arg 
                165                 170                 175     


Tyr Gln Ser Thr Ala Arg Thr Thr Tyr Thr Phe Ala Lys Pro Met Ala 
            180                 185                 190         


Ala Asn Ile Leu Lys Asn Gln Pro Met Phe Val Phe Arg Lys Thr Glu 
        195                 200                 205             


Leu Lys His Ser Lys Thr Glu Leu Asn Phe Lys Glu Trp Gln Lys Ala 
    210                 215                 220                 


Phe Thr Asp Val Met Gly Met Asp Glu Leu Tyr Lys 
225                 230                 235     


